These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2900036)

  • 21. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of l-stepholidine on the peripheral vascular dopamine DA1 and DA2 receptor subtypes].
    Zhang W; Zhi J; Guo W; Zhao R; Jin G
    Yao Xue Xue Bao; 1998 Oct; 33(10):721-6. PubMed ID: 12016922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dopaminergic agonists and antagonists on the partially contracted, isolated and perfused renal artery of the rat.
    Rodriguez-Mendez SA; Feria M; Boada J
    Pharmacology; 1986; 32(6):321-5. PubMed ID: 3487804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs.
    Polak MJ; Drummond WH
    Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery.
    Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1983 Apr; 89(1-2):137-41. PubMed ID: 6861882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does leukotriene C4 mediate hypoxic vasoconstriction in isolated ferret lungs?
    Tseng CM; McGeady M; Privett T; Dunn A; Sylvester JT
    J Appl Physiol (1985); 1990 Jan; 68(1):253-9. PubMed ID: 2312466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurogenic vasodilatation produced by fenoldopam in the rat hindquarters vascular bed.
    Van der Niepen P; Lefebvre RA; Dupont AG
    J Auton Pharmacol; 1987 Dec; 7(4):331-8. PubMed ID: 2895108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised dog.
    Hilditch A; Drew GM
    J Cardiovasc Pharmacol; 1984; 6(3):460-9. PubMed ID: 6202973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries.
    Hughes AD; Sever PS
    Br J Pharmacol; 1989 Jul; 97(3):950-6. PubMed ID: 2474354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
    Zhao RR; Wang PH; Zhang WF; Fennell WH
    Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of DA1/DA2 dopamine receptor interactions in proximal tubules of spontaneously hypertensive rats.
    Vachvanichsanong P; Sela S; Sidhu A
    Am J Physiol; 1996 Jan; 270(1 Pt 2):F98-105. PubMed ID: 8769827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR; Bunney BS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.
    Hughes A; Thom S; Martin G; Redman D; Hasan S; Sever P
    Br J Clin Pharmacol; 1986 Nov; 22(5):535-40. PubMed ID: 2878679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of tetrahydroberberine on peripheral vascular dopamine DA1 and DA2 receptor subtypes].
    Zhang WF; Zhi JM; Guo W; Zhao RR; Jin GZ
    Zhongguo Zhong Yao Za Zhi; 2000 Aug; 25(8):497-500. PubMed ID: 12515216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine and new dopamine analogs: receptors and clinical applications.
    Goldberg LI
    J Clin Anesth; 1988; 1(1):66-74. PubMed ID: 2908484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
    Friedman DJ; Budai D; Krause DN; Duckles SP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):853-9. PubMed ID: 2674420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys.
    Bergman J; Madras BK; Spealman RD
    J Pharmacol Exp Ther; 1991 Sep; 258(3):910-7. PubMed ID: 1890625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.